Clinical Trials Directory

Trials / Conditions / Schizophrenia Spectrum and Other Psychotic Disorders

Schizophrenia Spectrum and Other Psychotic Disorders

45 registered clinical trials studyying Schizophrenia Spectrum and Other Psychotic Disorders12 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingComparative Effectiveness of Dapagliflozin, Metformin, and Lifestyle Modification for Antipsychotic-Induced We
NCT07342764
Sultan Qaboos UniversityPhase 4
Not Yet RecruitingStudy Comparing Antipsychotic Dose Reduction vs. Maintenance Treatment in Patients With Schizophrenia Spectrum
NCT07152184
University Hospital, Strasbourg, FrancePhase 2
RecruitingImmunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in Schizophreni
NCT06673966
Central South University
RecruitingSloMo2: Implementation, Effectiveness, and Cost-effectiveness Study
NCT06568081
King's College LondonN/A
Not Yet RecruitingThe Personalized Psychological Treatment for Psychosis
NCT06603922
Polish Academy of SciencesN/A
RecruitingVR-based Avatar Therapy for Treatment of Auditory Hallucinations
NCT06505564
Semmelweis UniversityN/A
RecruitingEffectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care Cl
NCT06624462
Bjorn H. EbdrupN/A
RecruitingSex, Psychopharmacology, and Diabetes
NCT05951660
Zealand University HospitalN/A
Active Not RecruitingEPI-MINN: Targeting Cognition and Motivation - National
NCT05877716
University of MinnesotaN/A
TerminatedMusic Therapy Advocacy Recording Intervention (MTAR) on Internalized Stigma
NCT05723328
Hackensack Meridian HealthN/A
RecruitingA Randomized Controlled Trial With Rituximab for Psychotic Disorder in Adults
NCT05622201
Region Örebro CountyPhase 2
RecruitingBiomarkers/Biotypes, Course of Early Psychosis and Specialty Services
NCT06740383
Beth Israel Deaconess Medical Center
RecruitingBenefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders
NCT06423651
Universitat Autonoma de BarcelonaN/A
CompletedAntipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients
NCT06040944
Fayoum University
CompletedState Representation in Early Psychosis - Project 4
NCT05664594
University of MinnesotaN/A
CompletedRemote State Representation in Early Psychosis
NCT05538832
University of MinnesotaEARLY_Phase 1
UnknownMindfulness, Empathy and the Oxytocinergic System in Persons With Schizophrenia
NCT05491486
Charite University, Berlin, GermanyN/A
CompletedPlan D- Vitamin D Supplementation in Psychotic Disorders
NCT05211635
University Hospital, AkershusN/A
CompletedCommunity Reinforcement Approach and Family Training for Substance Use in Early Psychosis Intervention
NCT05300633
Centre for Addiction and Mental HealthN/A
CompletedState Representation in Early Psychosis
NCT05273164
University of Minnesota
RecruitingCigarette Consumption After switchinG to High or Low Nicotine strENght E-cigaretteS In Smokers With Schizophre
NCT04452175
University of CataniaN/A
CompletedStudy to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
NCT05321602
Luye Pharma Group Ltd.Phase 1
CompletedAcceptance and Commitment Therapy-based Lifestyle Counselling Programme for Early Psychosis on Physical Activi
NCT04916496
Chinese University of Hong KongN/A
CompletedAscertaining Diagnosis Classification With Elicited Speech
NCT05601063
Northwell Health
CompletedED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
NCT04298450
Centre for Addiction and Mental HealthN/A
CompletedEarly Psychosis Intervention - Spreading Evidence-based Treatment
NCT03919760
Centre for Addiction and Mental HealthN/A
CompletedRituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019)
NCT03983018
Region Örebro CountyPhase 2
CompletedFamily Psychoeducation for Adults With Psychotic Disorders in Tanzania
NCT04013932
Duke UniversityN/A
UnknownMetacognitive Training and Insight in Schizophrenia
NCT04104347
Instituto de Investigación Sanitaria de la Fundación Jiménez DíazN/A
CompletedInsight Enhancement Program vs. Metacognitive Training for Psychosis in Patients With Schizophrenia: A Three-A
NCT03955549
Agiad Psychiatry HospitalPhase 3
TerminatedRepetitive TMS & Cognitive Training in Adults With Schizophrenia
NCT03741751
Washington University School of MedicineN/A
CompletedBerberine as Adjuvant Treatment for Schizophrenia Patients
NCT02983188
The University of Hong KongPhase 2 / Phase 3
CompletedTesting a New Device to Advance the Use of Social Skills Training With Mental Health Consumers and Clinicians
NCT03053557
Center for Social Innovation, MassachusettsN/A
UnknownMirror-image Study of Paliperidone Palmitate and Risperidone Long-acting Injection
NCT03390712
Réseau de Santé Vitalité Health Network
CompletedBiomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia
NCT03323437
Weill Medical College of Cornell UniversityPhase 4
CompletedCopeptin in Outcome Prediction of an Acute Psychotic Episode
NCT03235908
University Hospital, Basel, Switzerland
CompletedFeasibility and Outcomes of a Digital Health Support for the Schizophrenia Spectrum
NCT03649815
Centre for Addiction and Mental HealthEARLY_Phase 1
CompletedPersonalizing Interventions Using Real-World Interactions
NCT04665401
Indiana UniversityN/A
UnknownPhenomics and Genomics of Clozapine Pharmacotherapy
NCT03253367
Jurjen Luykx
CompletedMulti-dimensional Investigations of Negative Emotions and Drug-resistant Auditory Verbal Hallucinations in Psy
NCT03449407
Chinese University of Hong Kong
CompletedCognitive Behavior Therapy for Patients With Psychoses.
NCT03501888
Karolinska InstitutetN/A
CompletedPACT for Individuals With Serious Mental Illness
NCT01668355
VA Office of Research and DevelopmentN/A
Unknown10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals
NCT03090490
Fundación Marques de ValdecillaN/A
CompletedLow Pulse Amplitude Seizure Therapy (LAP-ST Study)
NCT02928159
Behman HospitalPhase 1
Completed3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals
NCT02220504
Fundación Marques de ValdecillaN/A